Hiršl, L., Brizić, I., Jenuš, T., Juranić Lisnić, V., Reichel, J. J., Jurković, S. ... Jonjić, S. (2018). Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology, 9.. doi: 10.3389/fimmu.2018.00991
Hiršl, Lea, et al. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology, vol. 9, 2018. https://doi.org/10.3389/fimmu.2018.00991
Hiršl, Lea, Ilija Brizić, Tina Jenuš, Vanda Juranić Lisnić, Johanna Julia Reichel, Slaven Jurković, Astrid Krmpotić and Stipan Jonjić. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology 9 (2018). https://doi.org/10.3389/fimmu.2018.00991
Hiršl, L., et al. (2018) 'Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines', Frontiers in Immunology, 9. doi: 10.3389/fimmu.2018.00991
Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, and sur.. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology [Internet]. 2018 May 07 [cited 2024 November 14];9. doi: 10.3389/fimmu.2018.00991
L. Hiršl, et al., "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines", Frontiers in Immunology, vol. 9, May 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:653520. [Accessed: 14 November 2024]